HBV PCR Qualitative
HBV PCR detects hepatitis B virus DNA in the blood, confirming active viral replication. It is more sensitive than antigen/antibody tests and essential for treatment decisions and monitoring.
- DHA-licensed lab
- Includes Doctor Consultation
- Physician-reviewed
- Same Day Collection
2 to 3 days
Turnaround
Blood
Sample
What the HBV PCR Qualitative test tells you
Hepatitis B PCR looks directly for the virus's own genetic material in a blood sample. This is a different kind of evidence from the antigen and antibody tests: those describe the virus's outer proteins or your immune system's response to them, while PCR shows whether the virus itself is present and copying itself. The qualitative version reports simply whether viral DNA was detected, and a laboratory can also run a version that measures how much virus is present, which is the form usually chosen when treatment is being followed over time.
The test is read alongside the other hepatitis B results, never instead of them. The surface antigen establishes that infection is present; the antibody tests describe exposure or vaccination; PCR answers the separate question of whether the virus is actively replicating right now. That answer matters at several points: when deciding whether antiviral treatment is needed, when checking that treatment is working, before starting chemotherapy or any medicine that suppresses the immune system, since hepatitis B can become active again in that setting, and when liver tests are abnormal but the surface antigen is negative.
When the test is repeated, the direction of travel across results matters far more than any single one. Virus that becomes undetectable and stays that way is what treatment aims for, and a result that moves the other way prompts a review rather than alarm. It is worth stating plainly that hepatitis B is usually a long-term condition rather than one that is cured outright, but it is very manageable: with regular monitoring and, when it is needed, effective long-term antiviral treatment, most people keep the virus suppressed and their liver in good health for the long run. A positive result is a reason to see a doctor promptly for confirmation and a full assessment: it is not a catastrophe, and it is not something to interpret or act on by yourself.
Required for confirming active HBV replication, guiding treatment initiation, monitoring antiviral therapy, and screening blood donors.
- Confirms the virus is active
It distinguishes a virus that is actively replicating from an infection that is present but currently quiet, which the antigen test alone cannot do.
- Informs treatment decisions
Whether antiviral treatment is offered depends heavily on whether the virus is replicating, alongside liver tests and other assessments.
- Tracks response over time
Repeated testing shows whether treatment is holding the virus down, and the trend across results is what your doctor follows.
- Checks reactivation risk
Before chemotherapy or immune-suppressing medicines, this test helps identify people who need protective antiviral cover.
Reasons your doctor may request the HBV PCR Qualitative test
Your doctor may order this test for any of the reasons below. Some are routine checks, others follow specific symptoms or an earlier result.
Confirming active infection
- Assessment of someone whose hepatitis B surface antigen is positive, to establish whether the virus is replicating.
- Investigation of abnormal liver tests where hepatitis B is suspected despite a negative surface antigen.
Treatment & liver enzymes
- Monitoring while on antiviral treatment for hepatitis B.
- Unexplained abnormal liver enzymes in someone with known or previous hepatitis B.
Before immune-suppressing treatment & in pregnancy
- Before and during chemotherapy, biologic therapy or long-term steroids, where reactivation is a recognised risk.
- Pregnancy in a woman known to have hepatitis B, as part of planning care for mother and baby.
This test looks for the hepatitis B virus's own genetic material, so it is reported as "Not Detected" or "Detected" rather than as a number. "Detected" is direct evidence that the virus is replicating: a chronic infection that is active, a recent infection in the phase when the virus multiplies most, reactivation during chemotherapy or immune-suppressing treatment, or incomplete suppression on antiviral treatment. "Not Detected" is what treatment aims for, but it does not mean the virus has gone: hepatitis B can persist quietly in the liver and become active again later. Neither result describes how much damage the liver has sustained. A single result is a snapshot, and the trend across repeated tests guides management. Your doctor interprets it together with the antigen and antibody tests, your symptoms and your history.
Medically reviewed by Dr Nirupama Sabhapathy
This test is reported descriptively rather than on a numeric scale: each finding below explains what your report may say.
No hepatitis B DNA found in the blood; in known infection, the virus may still persist in the liver.
Hepatitis B DNA found: the virus is actively replicating; your doctor will guide monitoring and treatment.
Ranges are a guide: your physician interprets your result alongside your symptoms and history.
What a higher result can point to
- Chronic hepatitis B infection in which the virus is actively replicating.
- Recent hepatitis B infection during the phase when the virus is multiplying most.
- Reactivation of previously quiet hepatitis B, often triggered by chemotherapy or immune-suppressing treatment.
- Occult infection, where viral genetic material is present although the surface antigen test is negative.
- Incomplete suppression during antiviral treatment, which may reflect timing, adherence or reduced response.
These are possibilities, not diagnoses. A single value outside the reference range is interpreted alongside your symptoms, history and other tests: your doctor decides what it means for you.
What this test cannot tell you
- An undetectable result does not mean the virus has been eradicated; hepatitis B can persist quietly in the liver and become active again later.
- The test says nothing about how much damage the liver has sustained, which needs liver blood tests, imaging or other assessment.
- A single result is a snapshot; the pattern across repeated tests is far more informative than any one measurement.
- PCR is interpreted together with the antigen and antibody tests, not as a replacement for them.
Risks of the blood draw
- Mild bruising or brief soreness where the needle went in.
- Occasional lightheadedness, which settles after a few minutes of rest.
- Bleeding or infection at the site, which is rare with sterile single-use equipment.
- 1The test detects the virus's own genetic material, which is direct evidence of active infection.
- 2It complements the antigen and antibody tests rather than replacing them.
- 3Undetectable virus is the goal of treatment, but it is not the same as the infection being gone.
- 4The trend across repeated tests guides management more than any individual result.
- 5Hepatitis B is usually managed long term rather than cured, and with monitoring and treatment most people do well.
- STI & STDHepatitis B Surface Antigen (HBsAg)
HBsAg is the first detectable marker of hepatitis B infection. A positive result indicates active hepatitis B, either acute or chronic. This test is…
55View - BiochemistryLiver Function Test (LFT)
LFT is a comprehensive panel that evaluates liver health by measuring enzymes (ALT, AST, ALP, GGT), bilirubin, albumin, and total protein. It helps…
89View - BiochemistryAlanine Aminotransferase (ALT/SGPT)
ALT is a liver enzyme that is released into the blood when liver cells are damaged. This test helps detect liver inflammation or injury from…
15View - STI & STDHCV PCR Qualitative
HCV PCR detects hepatitis C virus RNA in the blood, confirming active infection. It is the essential follow-up test after a positive HCV antibody…
550View
Frequently Asked Questions
Everything you need to know about the HBV PCR Qualitative test. Can't find what you're looking for?
Talk to our team→A "Detected" result is direct evidence that hepatitis B virus is replicating in your blood. It can reflect an active chronic infection, a recent infection, reactivation during chemotherapy or immune-suppressing treatment, or incomplete suppression on antiviral treatment. It does not show how much the liver has been affected, so your doctor reads it with the antigen and antibody tests and liver blood tests.
This qualitative test answers one question: is hepatitis B genetic material present or not. It is reported as "Detected" or "Not Detected" rather than as a number. A quantitative viral load test measures how much virus is present, which some treatment and monitoring decisions need. Your doctor chooses which test fits the question being asked.
Yes. This is called occult hepatitis B: viral genetic material is present in the blood although the surface antigen test is negative. It is one reason PCR is used alongside the antigen and antibody tests rather than instead of them, particularly before immune-suppressing treatment or when liver tests are unexplained. Your doctor interprets the full pattern.
Because hepatitis B that has been quiet can reactivate when the immune system is suppressed, for example by chemotherapy. Checking for viral DNA, together with the antigen and antibody tests, helps your doctor decide whether you need protective antiviral treatment or closer monitoring during the course, rather than discovering a flare once it has begun.
No. HBV PCR shows whether the virus is present and replicating, but it says nothing about how much damage the liver has sustained. That needs liver blood tests, imaging or other assessment of scarring. Someone with detectable virus can have a healthy liver, and the reverse can also be true, which is why the tests are read together.
Not quite. It means the virus is not being found in your blood at present, which is reassuring and is the aim of treatment. Hepatitis B can persist quietly within liver cells even when nothing is detectable in blood, which is why monitoring continues and why treatment is not usually stopped on the strength of one good result. Your doctor will explain what your particular pattern means.
The two tests answer different questions. The surface antigen shows that hepatitis B infection is present; PCR shows whether the virus is actively multiplying at the moment. Someone can carry the infection with very little viral activity, and someone else can carry it with a great deal, and the management of those two situations differs. The tests are read together.
For most people it is managed rather than cured. That is a meaningful distinction but not a bleak one: modern antiviral treatment suppresses the virus very effectively, and with regular monitoring the great majority of people keep their liver healthy and live normally. Some people never need treatment at all and are simply followed up. Your doctor decides which path fits your results.
Because hepatitis B is a moving picture rather than a fixed one. Viral activity varies over months and years, and treatment is judged by whether the virus stays suppressed. Following the trend across repeated tests, together with liver blood tests, tells your doctor far more than any single result could.
No fasting is required and you can eat and drink normally. Keep taking your usual medicines as prescribed, and do not stop an antiviral before testing, since the point of monitoring is to see how well treatment is working.
The HBV PCR test is AED 550, including a physician-reviewed report, with results usually within 2 to 3 days. Collection at home anywhere in Dubai, or at our lab, is free with this test, because it reaches the AED 300 threshold on its own.